Índice

• • ·Editorial Board

    Página :i

    
• • ·Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: A cohort study of 8486 primary-care patients

    Página :306-313

    J. Bodegard, J. Sundström, B. Svennblad, C.J. Östgren, P.M. Nilsson, G. Johansson

    Resumen Resumen Esquema Esquema   
• • ·MRI measurement of liver fat content predicts the metabolic syndrome

    Página :314-321

    P.-H. Ducluzeau, J. Boursier, S. Bertrais, S. Dubois, A. Gauthier, V. Rohmer, F. Gagnadoux, G. Leftheriotis, P. Cales, R. Andriantsitohaina, V. Roullier, C. Aubé

    Resumen Resumen Esquema Esquema  
• • ·What is the phenotype of patients with gastrointestinal intolerance to metformin?

    Página :322-329

    M.P. Hermans, S.A. Ahn, M.F. Rousseau

    Resumen Resumen Esquema Esquema  
• • ·Fasting insulin at baseline influences the number of cardiometabolic risk factors and R-R interval at 3 years in a healthy population: The RISC Study

    Página :330-336

    Z. Pataky, A. Golay, M. Laville, E. Disse, A. Mitrakou, C. Guidone, R. Gabriel, E. Bobbioni-Harsch, RISC Investigators

    Resumen Resumen Esquema Esquema   
• • ·Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes

    Página :337-342

    R. Peter, G. Dunseath, S.D. Luzio, D.R. Owens

    Resumen Resumen Esquema Esquema  
• • ·Prevalence of treatment for diabetes during 1997–2007, and trends in cardiovascular risk factors between 2001 and 2007 according to diabetic treatment, in the IPC (Investigations Préventives et Cliniques; Preventive and Clinical Investigations) cohort

    Página :343-348

    F. Thomas, E. Eschwege, K. Bean, B. Pannier, N. Danchin

    Resumen Resumen Esquema Esquema  
• • ·Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus

    Página :349-354

    M. Genevieve, A. Vivot, C. Gonzalez, C. Raffaitin, P. Barberger-Gateau, H. Gin, V. Rigalleau

    Resumen Resumen Esquema Esquema  
• • ·Impaired endothelial function is not associated with arterial stiffness in adults with type 1 diabetes

    Página :355-362

    G. Llauradó, V. Ceperuelo-Mallafré, C. Vilardell, R. Simó, L. Albert, E. Berlanga, J. Vendrell, J.M. González-Clemente

    Resumen Resumen Esquema Esquema
• • ·Interference of the most frequent haemoglobin variants on quantification of HbA_1c: Comparison between the LC–MS (IFCC reference method) and three routinely used methods

    Página :363-369

    S. Jaisson, N. Leroy, C. Desroches, M. Tonye-Libyh, E. Guillard, P. Gillery

    Resumen Resumen Esquema Esquema  
• • ·A novel GATA6 mutation leading to congenital heart defects and permanent neonatal diabetes: A case report

    Página :370-374

    G. Catli, A. Abaci, S.E. Flanagan, E. De Franco, S. Ellard, A. Hattersley, H. Guleryuz, E. Bober

    Resumen Resumen Esquema Esquema   

• Editorial

  • ·Body weight and mortality in type 2 diabetes: Weighing up the evidence

    Página :287-288

    J. Logue, N. Sattar

    Resumen Resumen Esquema Esquema

• Reviews

  • ·The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes

    Página :290-298

    P. Iyngkaran, N. Anavekar, W. Majoni, M.C. Thomas

    Resumen Resumen Esquema Esquema  
  • ·Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: A review of the current evidence from clinical studies

    Página :299-305

    M. Vincent, E. Nobécourt

    Resumen Resumen Esquema Esquema

• Letter to the editor

  • ·Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes

    Página :375-376

    H. Nasri

    Resumen Resumen Esquema Esquema